Posting manually since Annbot seems to be broken.
Perhaps to appease China. But MT had already posted photos of Polestars earlier. I don't trust them. I'm thinking of NV.Also China is not exactly known to respect IP from abroad. No idea what this is all about, but giving IP to a company that manufactures in china and is partly owned by china is not exactly the right direction I want this to move ..
This sounds good on the surface, is at best a nothing burger under the surface but to me, this has a foul smell to it. Don't like it.
Simultaneous SPP that was made with a select few of current large shareholders.
It is a rather odd post that one isn’t it?!! Especially on such a highbrow forum as this one.Not sure what you mean by this? The SPP is limited to $30,000 for everyone, no exceptions (ASIC rules). There is no additional placement for large shareholders. Every Australian shareholder would be eligible to apply for the full $30k, likely more than 10,000 of us currently.
It is a rather odd post that one isn’t it?!! Especially on such a highbrow forum as this one.
A
Must be someone overseas.
My more specific guess is a disgruntled UK based investor that is upset about the 2021 AGM...
Not sure what you mean by this?
Was seeing posts about select people getting called about participating in the SPP so took a guess. Thanks for the info.
Didn't mean anything in particular by it. Just pointing out simultaneous events from the other side of the planet
View attachment 55633
View attachment 55636
While other costs remained largely unchanged with one exception, production and costs for samples rose by 14% in the last quarter. Do I see that correctly? If so, could it mean that more samples left the EVA than usual?
I was also surprised from the beginning. I would never have thought that Talga would/could be stuck with these costs for the nearly series production of samples. Presumably they get the costs covered in the binding purchase agreement. But it is impossible for us to guess what was negotiated.That should be largely the case (or production costs have increased for other reasons). However, "receipts by customers" are declining at the same time. Unfortunately, Talga has never been able to fulfil its announcements that fair, market-standard revenues would be generated through the test material provided (or I misunderstood their initial announcement due to the language barrier). I asked questions about this twice before the last webinars and they were ignored.